Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Melinta Therapeutics presents compounds for treating bacterial infections

Nov. 21, 2017

University of Texas System identifies novel sigma1/2 receptor modulators

Nov. 20, 2017

Sumitomo Dainippon Pharma discloses TLR7 antagonists

Nov. 20, 2017

University of California, Oakland divulges erbB inhibitors

Nov. 20, 2017

Rudong SIMR Biotech identifies novel GABRA5 inverse agonists

Nov. 20, 2017

Genoscience Pharma presents compounds for treating cancer

Nov. 20, 2017

Amgen presents novel apelin receptor agonists

Nov. 17, 2017

Shanghai De Novo Pharmatech has presented TLR8 agonists

Nov. 17, 2017

GlaxoSmithKline discloses novel EZH2 inhibitors

Nov. 17, 2017

Bayer discovers new vasopressin receptor antagonists

Nov. 17, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...